Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 03, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,000 | -- | 14,000 | |
| Aug 03, 2010 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,000 | -- | 14,000 | |
| Aug 05, 2015 | VP - Global Franchise | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,100 | $15.27 | 38,676 | |
| Aug 05, 2015 | VP - Global Franchise | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 14,100 | -- | -- | |
| Jul 27, 2007 | VP - Operations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,100 | -- | 14,100 | |
| Jul 27, 2007 | VP - Marketing | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,100 | -- | 14,100 | |
| Aug 15, 2006 | VP - Marketing | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,100 | -- | 14,100 | |
| Jul 22, 2015 | VP - Global Franchise | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,153 | -- | 14,153 | |
| Jul 19, 2023 | SVP International | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,168 | -- | 20,122 | |
| Jul 22, 2015 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,704 | -- | 14,704 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.